Answers are grounded in this paper and cite their sources.
Antibodies leverage their fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains to confer protection against pathogens. We sought to identify antibody features correlated with receptor binding inhibition at the systems level of influenza viruses. We developed a systems-predictive neutralizing antibody (SNAb) titer assay to simultaneously predict influenza receptor binding inhibition across multiple subtypes and isolates using specimens from H1- and H5-vaccinated non-human primates. We incorporated these results into a systems serology framework to assess contribution of antibody features to the phenotype. We find that Fcγ-receptor binding features are strongly associated with SNAb against H1 and H5 influenza in serum, while IgG, IgM, and IgA were enriched at the mucosa. These compartment-specific correlates of SNAb were further shaped by vaccination route. Collectively, we propose that influenza receptor binding inhibition can be predicted at scale and across anatomical sites using a systems-based approach.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: